Meril Life Sciences inks pact with Japan Lifeline to expand presence globally

Meril Life Sciences has joined forces with Japan Lifeline in a strategic alliance to expand its presence globally. Through this transformative collaboration, Japan Lifeline secures exclusive rights to introduce Meril's transcatheter Heart valve, Myval Octacor, following PMDA approval in Japan. 

This collaboration with Japan Lifeline marks a significant step towards expanding the reach of Myval Octacor and elevating the standard of care for patients undergoing TAVR/TAVI procedures. This pivotal partnership signifies a milestone for Meril, reflecting our commitment to advancing cardiovascular solutions on a global scale. To create a positive impact on patient outcomes, we anticipate this collaboration to reinforce Meril's standing as a preeminent global leader in the space of dynamic cardiovascular technology.

Explore in-depth coverage and statements from Meril Life Sciences and Japan Lifeline regarding their strategic alliance. Access the complete articles here:

• https://bit.ly/3t81dNg
• https://bit.ly/3TgAGIy